NCT01448057 Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu Status COMPLETED Phase PHASE3
NCT01446289 Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings Status COMPLETED Phase PHASE2
NCT01440582 Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients Status COMPLETED Phase PHASE1
NCT01438996 Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults Status COMPLETED Phase PHASE2
NCT01438554 Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma Status COMPLETED Phase PHASE1
NCT01437943 Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients Status TERMINATED Phase PHASE4
NCT01437267 Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants Status COMPLETED Phase PHASE2
NCT01434680 Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers Status COMPLETED Phase PHASE2
NCT01433107 Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis Status COMPLETED Phase PHASE3
NCT01428492 Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01425242 Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension Status TERMINATED Phase NA
NCT01424644 A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents Status COMPLETED Phase PHASE4
NCT01423084 Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years Status COMPLETED Phase PHASE3
NCT01412892 Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas Status COMPLETED Phase PHASE2
NCT01410474 Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan Status COMPLETED Phase PHASE3